Controlling Gene Expression with 2-5A Antisense
- 31 July 1999
- Vol. 18 (3) , 252-265
- https://doi.org/10.1006/meth.1999.0782
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Inhibition of telomerase increases the susceptibility of human malignant glioblastoma cells to cisplatin-induced apoptosisOncogene, 1998
- Nuclease-Resistant Composite 2‘,5‘-Oligoadenylate−3‘,5‘-Oligonucleotides for the Targeted Destruction of RNA: 2−5A-Iso-antisenseJournal of Medicinal Chemistry, 1998
- Methods for the Characterization of Phosphatase-Stabilized 2−5A-Antisense ChimerasBioconjugate Chemistry, 1998
- Telomerase Catalytic Subunit Homologs from Fission Yeast and HumanScience, 1997
- The state of the art in antisense researchNature Medicine, 1995
- Antisense Oligonucleotides as Therapeutic Agents—Is the Bullet Really Magical?Science, 1993
- Therapeutic Applications of OligonucleotidesAnnual Review of Pharmacology and Toxicology, 1992
- Constitutive expression of (2′–5′) oligo A synthetase confers resistance to picornavirus infectionNature, 1987
- NUCLEOSIDE PHOSPHOROTHIOATESAnnual Review of Biochemistry, 1985
- Automated solid-phase synthesis, separation, and stereochemistry of phosphorothioate analogs of oligodeoxyribonucleotidesJournal of the American Chemical Society, 1984